Bioventix Announcements

TR-1: Notification of major interest in shares. (more…)

Unaudited interim results for the six months ended 31st December 2017. (more…)

TR-1: Notification of major interest in shares. (more…)

Bioventix plc

(“Bioventix” or the “Company”)

Result of AGM

Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly passed.

(more…)

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, was notified on 19 October 2017 of the following transactions in its ordinary shares of 5 pence each (“Ordinary Shares”)
(more…)

TR-1: Notification of major interest in shares. (more…)

Bioventix plc (BVXP) announces its audited results for the year ended 30 June 2017.

(more…)

TR-1: Notification of major interest in shares. (more…)

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, announces a trading update.
(more…)

TR-1: Notification of major interest in shares. (more…)